Cargando…
Targeting Lysyl Oxidase Family Meditated Matrix Cross-Linking as an Anti-Stromal Therapy in Solid Tumours
SIMPLE SUMMARY: To improve efficacy of solid cancer treatment, efforts have shifted towards targeting both the cancer cells and the surrounding tumour tissue they grow in. The lysyl oxidase (LOX) family of enzymes underpin the fibrotic remodeling of the tumour microenvironment to promote both cancer...
Autores principales: | Setargew, Yordanos F.I., Wyllie, Kaitlin, Grant, Rhiannon D., Chitty, Jessica L., Cox, Thomas R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7865543/ https://www.ncbi.nlm.nih.gov/pubmed/33513979 http://dx.doi.org/10.3390/cancers13030491 |
Ejemplares similares
-
A first-in-class pan-lysyl oxidase inhibitor impairs stromal remodeling and enhances gemcitabine response and survival in pancreatic cancer
por: Chitty, Jessica L., et al.
Publicado: (2023) -
Inhibition of Lysyl Oxidase and Lysyl Oxidase-Like Enzymes Has Tumour-Promoting and Tumour-Suppressing Roles in Experimental Prostate Cancer
por: Nilsson, Maria, et al.
Publicado: (2016) -
The role of lysyl oxidase, the extracellular matrix and the pre-metastatic niche in bone metastasis()()
por: Gartland, Alison, et al.
Publicado: (2016) -
The Interactome of Cancer-Related Lysyl Oxidase and Lysyl Oxidase-Like Proteins
por: Vallet, Sylvain D., et al.
Publicado: (2020) -
Lysyl oxidases: linking structures and immunity in the tumor microenvironment
por: Tenti, Paolo, et al.
Publicado: (2019)